Lv5
1078 积分 2022-06-29 加入
Structure-based design and disulfide stapling of interfacial cyclic peptidic inhibitors from thymic stromal lymphopoietin (TSLP) receptor to competitively target TSLP
26天前
已完结
De Novo Discoveryof a Macrocyclic Peptide Antagonistof Interleukin-11 with Antirenal Fibrotic Efficacy
26天前
已完结
Structure-guided modulation of the IL-4/IL-4Rα interface: molecular recognition, therapeutic antibodies, and small-molecule opportunities
1个月前
已完结
Roles of group 2 innate lymphoid cells in development of steroid-resistant severe asthma and their therapeutic targets
1个月前
已完结
Recent updates on thymic stromal lymphopoietin as a therapeutic target for asthma
1个月前
已完结
Epithelial alarmins TSLP, IL-33, and IL-25 in asthma pathogenesis: mechanistic roles and therapeutic implications
1个月前
已完结
Therapeutic Potential of Tulisokibart and Anti-TL1A Therapy in Inflammatory Disorders: Current Insights and Future Directions
1个月前
已完结
Review Article: TL1A Inhibitors in IBD ‐ Mechanistic Rationale and Clinical Evidence
1个月前
已完结
Cryo-EM structure of the TL1A-DR3 complex and implications for the treatment of Inflammatory Bowel Disease
2个月前
已完结
Biocatalytic cascades enable manufacture of the macrocyclic peptide enlicitide
4个月前
已完结
皖公网安备34019202002308
